1. Bausch Health stock soars 8.6% premarket on news of patent settlement  MarketWatch
  2. Bausch Health resolves Xifaxan patent dispute with Actavis  Seeking Alpha
  3. Bausch Health (BHC) Stock: Flying On Patent Settlement  CNA Finance
  4. Full coverage